2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting
详细信息 查看全文
- 作者：Lawrence H. Einhorn ; Bernardo Rapoport ; Rudolph M. Navari…
- 关键词：CINV ; Multiple ; day chemotherapy ; High ; dose chemotherapy ; Breakthrough nauseas and vomiting ; NK1 receptor antagonists ; 5 ; HT3 receptor antagonists
- 刊名：Supportive Care in Cancer
- 出版年：2017
- 出版时间：January 2017
- 年：2017
- 卷：25
- 期：1
- 页码：303-308
- 全文大小：
- 刊物类别：Medicine
- 刊物主题：Oncology; Nursing; Nursing Research; Pain Medicine; Rehabilitation Medicine;
- 出版者：Springer Berlin Heidelberg
- ISSN：1433-7339
- 卷排序：25
文摘
PurposeThis review summarizes the recommendations for the prophylaxis of acute and delayed nausea and vomiting induced by multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting as agreed at the MASCC/ESMO Antiemetic Guidelines update meeting in Copenhagen in June 2015.